|
- End-of-Life Care: Managing Common Symptoms - AAFP
When medications are required, haloperidol and risperidone are effective options for delirium Nausea and vomiting should be treated with medications targeting the etiology
- Deprescribing: Discontinuing Medications Near the End of Life
Deprescribing explores the medical questions and ethical issues involved in withdrawing end of life medication for a patient recently referred to hospice Deprescribing is the process of discontinuing drugs when the risks outweigh the benefits in terms of a patient's care goals
- Beyond Drugs: Nonpharmacologic Ways to Manage Pain - WebMD
WebMD explains non-drug therapies and techniques to ease the pain of a life-threatening illness
- Non-Pharmacological Pain Management Therapies for Adults
Care guide for Non-Pharmacological Pain Management Therapies for Adults Includes: possible causes, signs and symptoms, standard treatment options and means of care and support
- Pharmacological Treatment for Terminal Agitation, Delirium and Anxiety . . .
Haloperidol is recommended in consensus-based guidelines for delirium and is widely used, but high-quality evidence about its efficacy is missing Better control of agitation or refractory delirium might be achieved with the addition of a benzodiazepine
- Use of Non-Pharmacological Interventions
Non-Pharmacological Interventions (NPIs) play a crucial role in palliative care by addressing physical, emotional, and psychosocial needs They provide comfort to patients with advanced and incurable diseases, augmenting traditional pharmacological treatments
- Hospice Medication Deprescribing Toolkit - NHPCO
Decision trees in the flow chart describe opportunities for deprescribing medications at the end of life This collection of independent deprescribing guidance documents can assist hospice agencies when evaluating if medications could be continued or deprescribed
- Deprescribing in end-of-life care
For non-medical prescribers (NMPs), it is important to consider deprescribing within all elements of their practice in an attempt to reduce pill burden and the subsequent ramifications of polypharmacy, with the aim of improving patient outcomes and care
|
|
|